Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo

References

• Al-Nedawi K, Meehan B, Micallef J, et al. (2008). Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10:619–24.
   PubMed Web of Science ®Google Scholar
• Altai M, Liu H, Ding H, et al. (2018). Affibody-derived drug conjugates: potent cytotoxic molecules for treatment of HER2 over-expressing tumors. J Control Release 288:84–95.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti L, Seow Y, Yin H, et al. (2011). Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341–5.
   PubMed Web of Science ®Google Scholar
• Bar J, Ofek E, Barshack I, et al. (2019). Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer. Lung Cancer 138:109–15.
   PubMed Web of Science ®Google Scholar
• Batrakova E, Kim M. (2015). Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219:396–405.
   PubMed Web of Science ®Google Scholar
• Betker JL, Angle BM, Graner MW, et al. (2019). The potential of exosomes from cow milk for oral delivery. J Pharm Sci 108:1496–505.
   PubMed Web of Science ®Google Scholar
• Byrne JD, Betancourt T, Brannon-Peppas L. (2008). Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 60:1615–26.
   PubMed Web of Science ®Google Scholar
• Chang A. (2011). Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer 71:3–10.
   PubMed Web of Science ®Google Scholar
• Chen F, Chen J, Yang L, et al. (2019). Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol 21:498–510.
   PubMed Web of Science ®Google Scholar
• Cheng H, Fang H, Xu R, et al. (2019). Development of a rinsing separation method for exosome isolation and comparison to conventional methods. Eur Rev Med Pharmacol Sci 23:5074–83.
   PubMed Web of Science ®Google Scholar
• Danhier F, Feron O, Préat V. (2010). To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–46.
   PubMed Web of Science ®Google Scholar
• Demory Beckler M, Higginbotham JN, Franklin JL, et al. (2013). Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics 12:343–55.
   PubMed Web of Science ®Google Scholar
• Dhaliwal A, Zheng G. (2019). Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: designing a new perspective in nanomedicine delivery. Theranostics 9:8091–108.
   PubMed Web of Science ®Google Scholar
• Doleschel D, Mundigl O, Wessner A, et al. (2012). Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts. J Nucl Med 53:304–11.
   PubMed Web of Science ®Google Scholar
• Emam SE, Abu Lila AS, Elsadek NE, et al. (2019). Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues. Eur J Pharm Biopharm 145:27–34.
   PubMed Web of Science ®Google Scholar
• Fan J, Bao Y, Meng X, et al. (2017). Mechanism of modulation through PI3K-AKT pathway about Nepeta cataria L.'s extract in non-small cell lung cancer. Oncotarget 8:31395–405.
   PubMedGoogle Scholar
• Golombek S, May J, Theek B, et al. (2018). Tumor targeting via EPR: strategies to enhance patient responses. Adv Drug Deliv Rev 130:17–38.
   PubMed Web of Science ®Google Scholar
• Haugrud A, Zhuang Y, Coppock J, et al. (2014). Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells. Breast Cancer Res Treat 147:539–50.
   PubMed Web of Science ®Google Scholar
• Huang SF, Chu SC, Hsieh YH, et al. (2018). Viola yedoensis suppresses cell invasion by targeting the protease and NF-κB activities in A549 and Lewis lung carcinoma cells. Int J Med Sci 15:280–90.
   PubMed Web of Science ®Google Scholar
• Jaque D, Martínez Maestro L, Del Rosal B, et al. (2014). Nanoparticles for photothermal therapies. Nanoscale 6:9494–530.
   PubMed Web of Science ®Google Scholar
• Kahlert C, Melo SA, Protopopov A, et al. (2014). Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 289:3869–75.
   PubMed Web of Science ®Google Scholar
• Kibria G, Ramos EK, Wan Y, et al. (2018). Exosomes as a drug delivery system in cancer therapy: potential and challenges. Mol Pharm 15:3625–33.
   PubMed Web of Science ®Google Scholar
• Kim M, Haney M, Zhao Y, et al. (2016). Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomedicine 12:655–64.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang Y, Mu J, et al. (2020). Transplantation of human mesenchymal stem-cell-derived exosomes immobilized in an adhesive hydrogel for effective treatment of spinal cord injury. Nano Lett 20:4298–305.
   PubMed Web of Science ®Google Scholar
• Li Y, Wu J, Wang J, et al. (2020). Gemcitabine loaded autologous exosomes for effective and safe chemotherapy of pancreatic cancer. Acta Biomater 101:519–30.
   PubMed Web of Science ®Google Scholar
• Meng W, Li L, Zhu G. (2020). Prospects and challenges of exosomes as drug delivery systems. Sheng wu yi Xue Gong Cheng Xue za Zhi = J Biomed Eng = Shengwu Yixue Gongchengxue Zazhi 37:714–20.
   PubMedGoogle Scholar
• Qiang L, Cai Z, Jiang W, et al. (2019). A novel macrophage-mediated biomimetic delivery system with NIR-triggered release for prostate cancer therapy. J Nanobiotechnol 17:83.
   PubMed Web of Science ®Google Scholar
• Qiao L, Hu S, Huang K, et al. (2020). Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics 10:3474–87.
   PubMed Web of Science ®Google Scholar
• Saari H, Lázaro-Ibáñez E, Viitala T, et al. (2015). Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of paclitaxel in autologous prostate cancer cells. J Control Release 220:727–37.
   PubMed Web of Science ®Google Scholar
• Salarpour S, Forootanfar H, Pournamdari M, et al. (2019). Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques. Daru 27:533–9.
   PubMed Web of Science ®Google Scholar
• Salehi M, Movahedpour A, Tayarani A, et al. (2020). Therapeutic potentials of curcumin in the treatment of non-small-cell lung carcinoma. Phytother Res 34:2557–76.
   PubMed Web of Science ®Google Scholar
• Savina A, Vidal M, Colombo M. (2002). The exosome pathway in K562 cells is regulated by Rab11. J Cell Sci 115:2505–15.
   PubMed Web of Science ®Google Scholar
• Skog J, Würdinger T, Van Rijn S, et al. (2008). Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470–6.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. (2011). Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Semin Immunopathol 33:441–54.
   PubMed Web of Science ®Google Scholar
• Temming K, Schiffelers RM, Molema G, et al. (2005). RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Update 8:381–402.
   PubMed Web of Science ®Google Scholar
• Théry C, Amigorena S, Raposo G, et al. (2006). Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 30:22.
   Google Scholar
• Trajkovic K, Hsu C, Chiantia S, et al. (2008). Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244–7.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–9.
   PubMed Web of Science ®Google Scholar
• Vázquez-Ríos A, Molina-Crespo Á, Bouzo B, et al. (2019). Exosome-mimetic nanoplatforms for targeted cancer drug delivery. J Nanobiotechnol 17:85.
   PubMed Web of Science ®Google Scholar
• Wang M, You S-K, Lee H-K, et al. (2020). Development and evaluation of docetaxel–phospholipid complex loaded self-microemulsifying drug delivery system: optimization and in vitro/ex vivo studies. Pharmaceutics 12:544.
   PubMed Web of Science ®Google Scholar
• Wei C, Yao X, Jiang Z, et al. (2019). Cordycepin inhibits drug-resistance non-small cell lung cancer progression by activating AMPK signaling pathway. Pharmacol Res 144:79–89.
   PubMed Web of Science ®Google Scholar
• Wu NZ, Da D, Rudoll TL, et al. (1993). Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue. Cancer Res 53:3765–70.
   PubMed Web of Science ®Google Scholar
• Xu H, Dong L, Bin Z, et al. (2020). Supramolecular self-assembly of a hybrid 'hyalurosome' for targeted photothermal therapy in non-small cell lung cancer. Drug Deliv 27:378–86.
   PubMed Web of Science ®Google Scholar
• Yang Q, Cheng L, Hu L, et al. (2020). An integrative microfluidic device for isolation and ultrasensitive detection of lung cancer-specific exosomes from patient urine. Biosens Bioelectron 163:112290.
   PubMed Web of Science ®Google Scholar
• Yang X, Liu Y, Li W, et al. (2017). DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel. Acta Biochim Biophys Sin 49:899–906.
   Google Scholar
• Yoo M-K, Park I-K, Lim H-T, et al. (2012). Folate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imaging. Acta Biomater 8:3005–13.
   PubMed Web of Science ®Google Scholar
• Yu KF, Zhang WQ, Luo LM, et al. (2013). The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation. Int J Nanomedicine 8:2473–85.
   PubMed Web of Science ®Google Scholar
• Zambito Y, Pedreschi E, Di Colo G. (2012). Is dialysis a reliable method for studying drug release from nanoparticulate systems? A case study. Int J Pharm 434:28–34.
   PubMed Web of Science ®Google Scholar
• Zhang E, Xing R, Liu S, et al. (2019). Current advances in development of new docetaxel formulations. Expert Opin Drug Deliv 16:301–12.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yang S, Wong L, et al. (2020). In vitro and in vivo comparison of curcumin-encapsulated chitosan-coated poly(lactic-co-glycolic acid) nanoparticles and curcumin/hydroxypropyl-β-cyclodextrin inclusion complexes administered intranasally as therapeutic strategies for Alzheimer's disease. Mol Pharm 17:4256–69.
   PubMed Web of Science ®Google Scholar
• Zhang S, Song W, Wu H, et al. (2020). Lecithins-Zein nanoparticles for antifungal treatment: enhancement and prolongation of drug retention in skin with reduced toxicity. Int J Pharm 590:119894.
   PubMed Web of Science ®Google Scholar